Australia and New Zealand conditionally clear Elanco/Bayer
Competition enforcers in Australia and New Zealand have cleared Elanco Animal Health’s €7 billion acquisition of Bayer’s animal health business after Elanco agreed to divest several products in each country.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.